Join the 200th Anniversary Celebration

Original Article

The Renal Arterial Resistance Index and Renal Allograft Survival

Jörg Radermacher, M.D., Michael Mengel, M.D., Sebastian Ellis, M.D., Stephan Stuht, M.D., Markus Hiss, M.D., Anke Schwarz, M.D., Ute Eisenberger, M.D., Michael Burg, M.D., Friedrich C. Luft, M.D., Wilfried Gwinner, M.D., and Hermann Haller, M.D.

N Engl J Med 2003; 349:115-124July 10, 2003

Abstract

Background

Most renal transplants fail because of chronic allograft nephropathy or because the recipient dies, but no reliable factor predicting long-term outcome has been identified. We tested whether a renal arterial resistance index of less than 80 was predictive of long-term allograft survival.

Methods

The renal segmental arterial resistance index (the percentage reduction of the end-diastolic flow as compared with the systolic flow) was measured by Doppler ultrasonography in 601 patients at least three months after transplantation between August 1997 and November 1998. All patients were followed for three or more years. The combined end point was a decrease of 50 percent or more in the creatinine clearance rate, allograft failure (indicated by the need for dialysis), or death.

Results

A total of 122 patients (20 percent) had a resistance index of 80 or higher. Eighty-four of these patients (69 percent) had a decrease of 50 percent or more in creatinine clearance, as compared with 56 of the 479 patients with a resistance index of less than 80 (12 percent); 57 patients with a higher resistance index (47 percent) required dialysis, as compared with 43 patients with a lower resistance index (9 percent); and 36 patients with a higher resistance index (30 percent) died, as compared with 33 patients with a lower resistance index (7 percent) (P<0.001 for all comparisons). A total of 107 patients with a higher resistance index (88 percent) reached the combined end point, as compared with 83 of those with a lower resistance index (17 percent, P<0.001). The multivariate relative risk of graft loss among patients with a higher resistance index was 9.1 (95 percent confidence interval, 6.6 to 12.7). Proteinuria (protein excretion, 1 g per day or more), symptomatic cytomegalovirus infection, and a creatinine clearance rate of less than 30 ml per minute per 1.73 m2 of body-surface area after transplantation also increased the risk.

Conclusions

A renal arterial resistance index of 80 or higher measured at least three months after transplantation is associated with poor subsequent allograft performance and death.

Media in This Article

Figure 1Univariate Relative Risk of a Decrease of 50 Percent or More in the Creatinine Clearance, the Need for Dialysis, or Death after Doppler Ultrasonography Associated with Selected Variables.
Figure 2Kaplan–Meier Analyses of Time to the Predefined Combined End Point and the Time to Each End Point Considered Separately.
Article

Chronic allograft nephropathy and death with a functioning allograft account for 80 percent of allograft failures.1,2 No measure accurately identifies patients at high risk for allograft loss. We recently found that a renal arterial resistance index of 80 or higher predicts a poor outcome of treatment after correction of renal-artery stenosis3 and also predicts worsening renal function or death in patients with renal diseases other than renal-artery stenosis.4,5 These findings prompted us to conduct a prospective study involving recipients of renal transplants. We investigated the long-term outcome in transplant recipients in whom the resistance index was measured at least 3 months after transplantation (median, 40 months; range, 3 to 317). We chose this time point because we wanted to ensure that recovery from any acute renal failure had occurred and that possible confounding influences of any complications of surgery were avoided. We also compared the predictive value of the resistance index with that of other factors associated with renal allograft failure.

Methods

Study Design and Study Patients

The ethics committee of the University of Hannover approved the study, and all patients gave written informed consent. Between August 1997 and November 1998, color Doppler ultrasonography was performed by a single investigator in 776 consecutive recipients of a renal transplant who were being followed in our outpatient clinic. A total of 175 of these patients were excluded from the study because they had undergone transplantation less than three months previously or because they had factors present on the day of ultrasonography that influenced the resistance-index value. Such factors included compression of the kidney by adjacent masses, acute tubular necrosis, untreated renal-artery stenosis resulting in a 50 percent reduction in the luminal diameter, hydronephrosis of grade 2 or worse, and acute rejection.6-9 The patients were prospectively stratified into two groups according to the resistance index for their transplant: those with an index of 80 or higher and those with an index of less than 80.

Primary End Point

The combined primary end point was a reduction of 50 percent or more in the creatinine clearance rate from the value measured at the time of ultrasonography, development of end-stage renal failure requiring the reinstitution of dialysis, or death with a functioning graft. The creatinine clearance rate (in milliliters per minute per 1.73 m2 of body-surface area) and the rate of urinary protein excretion were measured during the 24 hours preceding the ultrasonographic examination and at yearly intervals thereafter. Urine collections were judged complete on the basis of quantification of the total creatinine excretion, corrected for age and sex. If the total creatinine excretion was 25 percent or more below the expected value (as it was for 91 of 601 patients), the creatinine clearance rate was estimated according to the Gault–Cockroft formula.10 Dialysis status and vital status were ascertained from the patients or their relatives. The mean (±SD) duration of follow-up for patients with uncensored data (i.e., patients who did not reach the combined end point) was 4.2±0.3 years (range, 3.3 to 4.9).

Ultrasonographic Determination of the Resistance Index

Either an Ultramark 9 HDI ultrasound machine (Advanced Technology Laboratories) with a 2-to-4-MHz curved-array multifrequency transducer with a 2.5-MHz pulsed Doppler frequency or a Sienna Sonoline ultrasound machine (Siemens) with a 3.5-MHz convex-array transducer was used. The B-mode measurements were performed at the same time as the Doppler measurement of the resistance index. The ultrasonographic procedure has been described previously.3,11 Briefly, the maximal length, width, and depth of the kidney were determined, and the renal volume was calculated as one half the product of the three dimensions. The renal parenchymal width was measured from the capsule to the tip of a renal pyramid.

Intrarenal Doppler signals were obtained from two to three representative proximal segmental arteries (the first vessels branching off the main renal artery). The peak systolic velocity (Vmax) and the minimal diastolic velocity (Vmin) were determined, the renal segmental arterial resistance index was calculated as 100 × [1 – (Vmin ÷ Vmax)], and the results from the two or three measurements were averaged. The reproducibility of resistance-index measurements was tested in 12 renal-transplant recipients by two independent investigators on two consecutive days in order to calculate the intraobserver, intrasession variability; the intraobserver, intersession variability; and the interobserver, intrasession variability. The respective values for the coefficient of variation were 2.2 percent, 4.8 percent, and 3.7 percent.

In order to rule out renal-artery stenosis in the transplant, the course of the renal artery was determined with color-flow imaging. Stenosis was suspected if a segment of the vessel showed color-flow disturbance (“aliasing”). The maximal systolic-flow velocity was measured at the site of aliasing (Vsten) and at the point most distal to the site (Vpoststen). The area of stenosis (as a percentage of the total area) was calculated according to the continuity equation as 100 × [1 – (Vpoststen ÷ Vsten)]. With the use of this approach, a stenosis resulting in a reduction in the area of 75 percent or more (equivalent to a reduction in the diameter of 50 percent or more) was diagnosed only when Vsten exceeded Vpoststen by a factor of four or more. The sensitivity, specificity, and positive and negative predictive values of this method for detecting a reduction in the diameter of 50 percent or more, when verified against the findings on selective angiography in 70 renal-transplant recipients, were 100 percent, 88 percent, 96 percent, and 100 percent, respectively (unpublished data).

Biopsy Substudy

In addition to performing this ultrasonographic procedure in the 601 patients with long-term follow-up, we also performed it in another 141 patients who, starting in December 2000, routinely underwent biopsy six months after transplantation as part of a biopsy program designed to guide routine clinical care. We compared their resistance-index values with histologic findings suggestive of chronic allograft nephropathy according to Banff 97 criteria.12 The presence or absence of tubular atrophy, interstitial fibrosis, chronic allograft nephropathy (i.e., the combination of tubular atrophy and interstitial fibrosis), and chronic allograft arteriopathy (fibrous intimal thickening) was noted, and the findings were graded from 0 to 3. In addition, global glomerulosclerosis was evaluated semiquantitatively (with 0 denoting no globally scarred glomeruli, 1 denoting less than 25 percent globally scarred glomeruli, 2 denoting 25 to 50 percent, and 3 denoting more than 50 percent). The same histologic criteria were applied to a subgroup of the 601 patients for whom biopsy was indicated because of worsening renal function or proteinuria at least one year after transplantation (median, 5.2 years; range, 1.0 to 20.3). In these patients, ultrasonography was performed a median of 1.3 years before biopsy (range, 4.2 years before biopsy to 1.7 years after biopsy).

Statistical Analysis

The SPSS statistical package (version 11.0, SPSS) and SAS software (version 8.2, SAS Institute) were used for all statistical analyses. Unpaired t-tests, chi-square analysis, or Kaplan–Meier analysis with the log-rank test was used as appropriate to assess the differences between groups. Cox proportional-hazards analysis was used to calculate univariate and multivariate hazard ratios as estimates of relative risks. The number of years of follow-up was calculated from the date of ultrasonography until the date of a first event or the last documented visit in our outpatient clinic. For multivariate analysis, the effect of multiple variables on worsening of renal function, need for dialysis, and death was evaluated in all 601 cases with stepwise forward Cox regression analysis (with P=0.10 as the threshold level of significance for the removal of the variable from analysis and P=0.05 as the threshold for entry into the model).

The variables investigated were the resistance index; the number of renal transplantations; the cold-ischemia time; the solution used for perfusion; the presence or absence of cytomegalovirus viremia and symptomatic infection; the age of the donor; the number of mismatches at the HLA-A, B, and DR loci; the number of acute interstitial and vascular rejections within and after the first three months after renal transplantation; the occurrence or nonoccurrence of a delay in graft function of more than six days after transplantation13; the percentage of panel-reactive antibodies; whether the graft was from a living or cadaveric donor; the type of underlying renal disease; the duration of dialysis; the sex of the patient; whether transplantation occurred before or after the introduction of cyclosporine; the age of the patient; the presence or absence of atherosclerosis in the heart, legs, or central nervous system; the presence or absence of diabetes; the presence or absence of hypertension; the mean systolic and diastolic blood pressure and pulse pressure as measured at home; the degree of proteinuria; the creatinine clearance rate; and the size, volume, and parenchymal width of the transplanted kidney. The pulse rate, the fasting serum glucose level, the C-reactive protein level, cholesterol levels, the uric acid level, height, and weight were always measured on the day of the ultrasonographic investigation, usually within two hours before ultrasonography, and information on concomitant drug use (angiotensin-converting–enzyme inhibitors, angiotensin-receptor blockers, calcium-channel blockers, beta-blockers, diuretics, alpha-blockers, moxonidine, clonidine, other antihypertensive drugs, and statins) was always obtained on that day as well.

Extrapolations of median survival times were performed with regression analysis (with SAS software), with the assumption of a gamma distribution. All data are expressed as means ±SD unless otherwise stated.

Results

The Resistance Index as a Predictor

Follow-up data were available for all 601 patients (Table 1Table 1Demographic and Clinical Characteristics of the Patients and Their Allografts at Base Line.). Patients with resistance-index values of 80 or higher were significantly older, had had their transplants for a longer time, had higher blood pressure, had worse graft function, had more severe proteinuria, and were more likely to have coronary artery disease than patients with resistance-index values below 80. However, only a resistance-index value of 80 or higher accurately identified patients who subsequently had a decrease of 50 percent or more in the creatinine clearance, required dialysis, or died (sensitivity, 56 percent; specificity, 96 percent).

A total of 122 patients (20 percent) had a resistance index of 80 or higher. Eighty-four of these patients (69 percent) had a decrease of 50 percent or more in the creatinine clearance rate, as compared with 56 of the 479 patients with a resistance index of less than 80 (12 percent); 57 patients with a higher resistance index (47 percent) required dialysis, as compared with 43 patients with a lower resistance index (9 percent); and 36 patients with a higher resistance index (30 percent) died, as compared with 33 patients with a lower resistance index (7 percent) (P<0.001 for all comparisons). A total of 107 patients with a higher resistance index (88 percent) reached the combined end point, as compared with 83 of those with a lower resistance index (17 percent; P<0.001). The resistance index was the strongest predictor of the combined end point (Table 2Table 2Sensitivity, Specificity, and Positive and Negative Predictive Values of the Renal Resistance Index and Other Factors for the Prediction of the Combined End Point of a Decrease of at Least 50 Percent in the Creatinine Clearance Rate, the Need for Dialysis, or Death.).

This finding was not altered when the variables were considered as continuous rather than dichotomous variables or when patients were stratified according to quintiles of age, time since transplantation, creatinine clearance rate, or degree of proteinuria (data not shown). The sensitivity of the resistance index improved to 65 percent (73 of 113) when the analysis included only the 113 patients who had graft failure due to biopsy-proved chronic allograft nephropathy (83 patients) or death from cardiovascular causes (30). The other major causes of a decrease of 50 percent or more in the creatinine clearance rate were recurrent disease (in 11 patients), rejection (in 7), and acute renal failure (in 5). Six patients had allograft failure from other known causes, and 19 had allograft failure from unknown causes. Noncardiovascular causes of death included infection (in 10 patients), cancer (in 10), other known causes (in 6), and unknown causes (in 13).

Other Possible Predictors

Univariate analysis revealed a number of variables that differed significantly between the patients who reached the combined end point and those who did not (Figure 1Figure 1Univariate Relative Risk of a Decrease of 50 Percent or More in the Creatinine Clearance, the Need for Dialysis, or Death after Doppler Ultrasonography Associated with Selected Variables.). However, none of these variables had a discriminatory power equal to that of the resistance index, as evidenced by the lower relative risks associated with these variables. Multivariate analysis of the combined end point (Table 3Table 3Relative Risk of Allograft Loss among the 601 Patients, According to Selected Risk Factors.) or the various end points separately (Table 4Table 4Relative Risk of a Decrease of 50 Percent or More in the Creatinine Clearance Rate, the Need for Dialysis, or Death, According to Selected Variables.) did not alter these findings. Moxonidine treatment, although used in only a small number of patients, was the only factor that significantly reduced the risk of the combined end point in the multivariate analysis (Table 3).

Prediction of Death

Kaplan–Meier curves for the combined end point of a reduction of 50 percent or more in the creatinine clearance rate, the need for dialysis, or death and for all end points considered separately (Figure 2Figure 2Kaplan–Meier Analyses of Time to the Predefined Combined End Point and the Time to Each End Point Considered Separately.) were calculated for the group with a resistance index of 80 or higher and the group with a resistance index of less than 80. When patients who died were included in the analysis, patients with a resistance index of 80 or higher had a median allograft survival of 2.5 years (95 percent confidence interval, 2.3 to 2.6), as compared with 23.3 years (95 percent confidence interval, 5.4 to 100.5) among patients with a resistance index of less than 80.

Verification of Cutoff

In an analysis using a receiver-operating-characteristic curve, we retrospectively evaluated the accuracy of the predefined cutoff value for the resistance index. The highest sensitivity (56 percent) and specificity (96 percent) were attained at a resistance-index value of 0.795, confirming the accuracy of the predefined value of 0.80.

Correlations with Other Measures

Among the 141 additional patients who underwent biopsy at six months, tubular atrophy occurred more frequently among patients with a resistance index of 80 or higher than among those with a lower resistance index (relative risk, 8.6; 95 percent confidence interval, 1.1 to 67) but the semiquantitative histologic scores were not correlated with the resistance index. However, direct correlations were observed between the resistance index and the degree of interstitial fibrosis (R2=0.07), the degree of tubular atrophy (R2=0.07), the degree of chronic allograft nephropathy (R2=0.07), the degree of chronic allograft arteriopathy (R2=0.11), and the sum of the scores for chronic allograft nephropathy and chronic allograft arteriopathy (R2=0.12) among the 187 patients in the main study in whom an indicated biopsy was performed at least one year after transplantation (P<0.001 for all correlations). No correlation was observed between the glomerulosclerosis score and the resistance index (R2=0.02, P=0.08).

Among the 601 study patients, direct correlations (P<0.001) were also observed between the resistance index and the age of the recipient (R2=0.20), the pulse pressure (R2=0.14), the systolic blood pressure (R2=0.04), the degree of proteinuria (R2=0.04), the base-line serum creatinine concentration (R2=0.04), and the blood glucose concentration (R2=0.03). Inverse correlations were observed between the resistance index and the diastolic blood pressure (R2=0.04) and between the resistance index and the creatinine clearance rate (R2=0.05). These factors explained 34 percent of the variation in the resistance index (R2=0.34).

Discussion

We found that a resistance index of 80 or higher in an allograft was a strong predictor of both allograft failure and death with a functioning graft. Various risk factors — including older age of the donor or the recipient, poorer renal function at one year, the presence of proteinuria, the presence and the degree of hypertension, a greater number of HLA mismatches, delayed graft function, and longer time since transplantation — have all been proposed as means for differentiating between patients with a good chance of long-term survival of a renal allograft and those with a poor chance.13-17 These factors also came into play in our study. However, none of them, alone or in combination,18 had a predictive value approaching that of an increased resistance-index value.

Since the resistance index is significantly correlated with many established cardiovascular risk factors, such as age, coronary heart disease, increased systolic and pulse pressure, and decreased renal function, it is not surprising that increased renal vascular resistance predicts not only graft failure but also death due to cardiovascular disease. Cardiovascular disease is the major cause of death in renal-transplant recipients. Several authors have found an increased resistance index particularly in patients who have signs of hypertensive end-organ damage such as microalbuminuria, left ventricular hypertrophy, increased carotid-wall thickness, and overt carotid atherosclerosis.19-21 The resistance index during long-term follow-up has been used to diagnose allograft nephropathy.6,22 No close association was observed between the resistance index and renal histology in these earlier studies or in our investigation.23 Trillaud et al. did not find a relation between the resistance index measured 6 days after renal transplantation and the level of renal function at 12 months.24 However, these investigators did not use the resistance index to predict allograft survival or death with a functioning graft.

The renal resistance index is nonspecific and is influenced by many factors. Some are unrelated to disease. For example, the site at which renal resistance is measured25 and the increased intraabdominal pressure during forced inspiration (the Valsalva maneuver) influence the index.26 A pulse rate of less than 50 beats per minute may increase the resistance index, and a pulse rate of more than 70 beats per minute may lower it.27 Finally, increasing age is also associated with an increased resistance index, particularly in hypertensive patients.28 Two common renal diseases that are associated with an increased renal resistance index are diabetic and hypertensive nephrosclerosis.29 Other diseases that also increase the index are acute renal failure and urinary tract obstruction with hydronephrosis. We attempted to exclude all extrarenal variables. We carefully excluded patients with potentially reversible renal disease states such as urinary tract obstruction and acute rejection.

The resistance index was correlated not with the histologic features of the allograft at six months, as was seen in the 141 patients in the biopsy study but, rather, with histologic findings obtained at least one year after transplantation. However, the latter results are confounded by the fact that only 31 percent of the 601 renal-transplant recipients underwent a renal biopsy. Thus, we are not able to rule out sampling errors entirely.12 Moreover, the resistance index was correlated more closely with characteristics of the recipients, such as age and arterial pulse pressure, suggesting that extrarenal factors have a major effect on the resistance index in the allograft.9,30 The factors influencing the resistance index explained only 34 percent of the variation we found in the resistance index. Thus, there are other operative variables that we were unable to define.

We observed a possible favorable effect exerted by moxonidine treatment for hypertension in cyclosporine-treated patients. This observation may be spurious, since the numbers were small. Nevertheless, cyclosporine has been shown to increase sympathetic-nerve activity31 and to decrease brachial-artery distensibility.32 Since an increased resistance index was correlated most closely with the pulse pressure, a crude marker of vascular stiffness, a substance such as moxonidine that inhibits sympathetic-nerve activity could positively influence vascular stiffness in renal-transplant recipients. Other drugs that could be tested for their effect on the resistance index are lisinopril,33 the prostacyclin analogue iloprost,34 and tacrolimus.35 The use of the Euro–Collins solution for perfusion of the allograft has been associated with higher resistance and poorer outcomes than the University of Wisconsin solution not only in our study, but also in another study.36

Our study has several limitations. We did not perform renal histologic analyses in all 601 patients, nor did we routinely perform parallel duplex ultrasonographic studies in these patients. However, our more recent patients are undergoing repeated biopsies and parallel duplex ultrasonographic studies on a regular basis. The histologic findings will have to be graded quantitatively in order to permit better correlation with the results on ultrasonography. The data we obtained at six months from the biopsies specified in the protocol probably did not represent sufficiently long-term follow-up to permit a highly sensitive comparison between histologic features and the resistance index.

We suggest that a Doppler ultrasonographic study performed three or more months after transplantation can predict long-term allograft outcomes. Our data also suggest that longitudinal Doppler studies may be useful in monitoring interventions such as different immunosuppressive protocols or in comparing the capability of various antihypertensive drugs to improve allograft outcomes. Such studies may reduce the need for sequential renal biopsies, with their associated risks. However, an increased resistance index could mean acute vascular rejection with endarteritis, chronic allograft nephropathy, or both. Only a renal biopsy can distinguish among these conditions.

Dr. Radermacher reports having received lecture fees from Pfizer. Dr. Luft reports having received lecture fees from Astra, Novartis, and Aventis and grant support from Boehringer Ingelheim, Novartis, and Pharmacia for basic research. Dr. Gwinner reports having received grant support from Novartis and Roche. Dr. Haller reports having received consulting fees, grant support, and lecture fees from Sankyo, consulting fees and lecture fees from Bayer, lecture fees from Aventis and Pfizer, lecture fees and grant support from Sanofi, and grant support from Roche and Baxter.

We are indebted to Dr. Hartmut Hecker and Dr. Ludwig Hoy for their assistance with the statistical analysis, and to Mrs. Carola Ausmeier and Mrs. Larissa Stettinger for their assistance with data acquisition.

Source Information

From the Departments of Nephrology (J.R., S.E., S.S., M.H., A.S., U.E., M.B., W.G., H.H.) and Pathology (M.M.), Hannover Medical School, Hannover, Germany; and the Franz Volhard Clinic, HELIOS Klinikum-Berlin, Humboldt University of Berlin, Berlin, Germany (F.C.L.).

Address reprint requests to Dr. Radermacher at the Department of Nephrology, Medizinische Hochschule Hannover, P.O. Box 61 01 80, D-30625 Hannover, Germany, or at .

References

References

  1. 1

    Kreis HA, Ponticelli C. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation 2001;71:Suppl:SS5-SS9
    Web of Science | Medline

  2. 2

    Howard RJ, Patton PR, Reed AI, et al. The changing causes of graft loss and death after kidney transplantation. Transplantation 2002;73:1923-1928
    CrossRef | Web of Science | Medline

  3. 3

    Radermacher J, Chavan A, Bleck J, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001;344:410-417
    Full Text | Web of Science | Medline

  4. 4

    Radermacher J, Ellis S, Haller H. Renal resistance index and progression of renal disease. Hypertension 2002;39:699-703
    CrossRef | Web of Science | Medline

  5. 5

    Petersen LJ, Petersen JR, Talleruphuus U, Ladefoged SD, Mehlsen J, Jensen HA. The pulsatility index and the resistive index in renal arteries: associations with long-term progression in chronic renal failure. Nephrol Dial Transplant 1997;12:1376-1380
    CrossRef | Web of Science | Medline

  6. 6

    Don S, Kopecky KK, Filo RS, et al. Duplex Doppler US of renal allografts: causes of elevated resistive index. Radiology 1989;171:709-712
    Web of Science | Medline

  7. 7

    Skotnicki SH, van Asten WN, Beijneveld WJ, van Roosmalen R, Hoitsma AJ, Wijn PF. Evaluation of renal allograft function by Doppler spectrum analysis: a preliminary study. Transpl Int 1989;2:16-22
    CrossRef | Web of Science | Medline

  8. 8

    Pozniak MA, Kelcz F, Stratta RJ, Oberley TD. Extraneous factors affecting resistive index. Invest Radiol 1988;23:899-904
    CrossRef | Web of Science | Medline

  9. 9

    Restrepo-Schafer IK, Schwerk WB, Muller TF, Prinz H, Gorg C, Arnold R. Intrarenal Doppler flow analysis in patients with kidney transplantation and stable transplant function. Ultraschall Med 1999;20:87-92
    CrossRef | Web of Science | Medline

  10. 10

    Gault MH, Longerich LL, Harnett JD, Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992;62:249-256
    CrossRef | Medline

  11. 11

    Radermacher J, Chavan A, Schaffer J, et al. Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize technical failure. Clin Nephrol 2000;53:333-343
    Web of Science | Medline

  12. 12

    Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-723
    CrossRef | Web of Science | Medline

  13. 13

    Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998;54:972-978
    CrossRef | Web of Science | Medline

  14. 14

    Opelz G, Sasaki N, Terasaki PI. Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation 1978;25:212-215
    CrossRef | Web of Science | Medline

  15. 15

    Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000;343:1078-1084
    Full Text | Web of Science | Medline

  16. 16

    Ponticelli C, Villa M, Cesana B, Montagnino G, Tarantino A. Risk factors for late kidney allograft failure. Kidney Int 2002;62:1848-1854
    Web of Science | Medline

  17. 17

    Mange KC, Cizman B, Joffe M, Feldman HI. Arterial hypertension and renal allograft survival. JAMA 2000;283:633-638
    CrossRef | Web of Science | Medline

  18. 18

    Hennige M, Kohler CO, Opelz G. Multivariate prediction model of kidney transplant success rates. Transplantation 1986;42:491-493
    CrossRef | Web of Science | Medline

  19. 19

    Pontremoli R, Viazzi F, Martinoli C, et al. Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. Nephrol Dial Transplant 1999;14:360-365
    CrossRef | Web of Science | Medline

  20. 20

    Shimizu Y, Itoh T, Hougaku H, et al. Clinical usefulness of duplex ultrasonography for the assessment of renal arteriosclerosis in essential hypertensive patients. Hypertens Res 2001;24:13-17
    CrossRef | Web of Science | Medline

  21. 21

    Alterini B, Mori F, Terzani E, et al. Renal resistive index and left ventricular hypertrophy in essential hypertension: a close link. Ann Ital Med Int 1996;11:107-113
    Medline

  22. 22

    Drudi FM, Cascone F, Pretagostini R, et al. Role of color Doppler US in the evaluation of renal transplant. Radiol Med (Torino) 2001;101:243-250

  23. 23

    Breitenseher M, Helbich T, Kainberger F, et al. Color Doppler ultrasound of kidney transplants: does the resistance index facilitate diagnosis of chronic kidney failure? Ultraschall Med 1994;15:24-28
    CrossRef | Web of Science | Medline

  24. 24

    Trillaud H, Merville P, Tran Le Linh P, Palussiere J, Potaux L, Grenier N. Color Doppler sonography in early renal transplantation follow-up: resistive index measurements versus power Doppler sonography. AJR Am J Roentgenol 1998;171:1611-1615
    Web of Science | Medline

  25. 25

    Martinoli C, Bertolotto M, Crespi G, Pretolesi F, Valle M, Derchi LE. Duplex Doppler analysis of interlobular arteries in transplanted kidneys. Eur Radiol 1998;8:765-769
    CrossRef | Web of Science | Medline

  26. 26

    Takano R, Ando Y, Taniguchi N, Itoh K, Asano Y. Power Doppler sonography of the kidney: effect of Valsalva's maneuver. J Clin Ultrasound 2001;29:384-388
    CrossRef | Web of Science | Medline

  27. 27

    Schwerk WB, Restrepo IK, Prinz H. Semiquantitative analysis of intrarenal arterial Doppler flow spectra in healthy adults. Ultraschall Med 1993;14:117-122
    CrossRef | Web of Science | Medline

  28. 28

    Boddi M, Sacchi S, Lammel RM, Mohseni R, Serneri GG. Age-related and vasomotor stimuli-induced changes in renal vascular resistance detected by Doppler ultrasound. Am J Hypertens 1996;9:461-466
    CrossRef | Web of Science | Medline

  29. 29

    Radermacher J. Ultrasonography in the diagnosis of renovascular disease. Imaging Decis 2002;6:15-22
    CrossRef

  30. 30

    Krumme B, Grotz W, Kirste G, Schollmeyer P, Rump LC. Determinants of intrarenal Doppler indices in stable renal allografts. J Am Soc Nephrol 1997;8:813-816
    Web of Science | Medline

  31. 31

    Gerhardt U, Riedasch M, Hohage H. Cyclosporine A modulates baroreceptor function in kidney transplant recipients. Int J Cardiol 1999;68:203-208
    CrossRef | Web of Science | Medline

  32. 32

    Kosch M, Barenbrock M, Kisters K, Rahn KH, Hausberg M. Relationship between muscle sympathetic nerve activity and large artery mechanical vessel wall properties in renal transplant patients. J Hypertens 2002;20:501-508
    CrossRef | Web of Science | Medline

  33. 33

    Leoncini G, Martinoli C, Viazzi F, et al. Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS. Nephron 2002;90:169-173
    CrossRef | Medline

  34. 34

    Scorza R, Rivolta R, Mascagni B, et al. Effect of iloprost infusion on the resistance index of renal vessels of patients with systemic sclerosis. J Rheumatol 1997;24:1944-1948
    Web of Science | Medline

  35. 35

    Radermacher J, Meiners M, Bramlage C, et al. Pronounced renal vasoconstriction and systemic hypertension in renal transplant patients treated with cyclosporin A versus FK 506. Transpl Int 1998;11:3-10
    CrossRef | Web of Science | Medline

  36. 36

    Bittard H, Benoit G, Moukarzel M, et al. Decrease in renal vascular resistance in University of Wisconsin solution preserved kidney transplants. J Urol 1991;146:1-4
    Web of Science | Medline

Citing Articles (83)

Citing Articles

  1. 1

    M. B. Damasio, G. Cittadini, D. Rolla, F. Massarino, N. Stagnaro, M. Gherzi, E. Paoletti, L. E. Derchi. (2012) Ultrasound findings in dual kidney transplantation. La radiologia medica
    CrossRef

  2. 2

    S. Seiler, S. M. Colbus, G. Lucisano, K. S. Rogacev, M. K. Gerhart, M. Ziegler, D. Fliser, G. H. Heine. (2012) Ultrasound renal resistive index is not an organ-specific predictor of allograft outcome. Nephrology Dialysis Transplantation
    CrossRef

  3. 3

    R. Kramann, D. Frank, V. M. Brandenburg, N. Heussen, J. Takahama, T. Kruger, J. Riehl, J. Floege. (2012) Prognostic impact of renal arterial resistance index upon renal allograft survival: the time point matters. Nephrology Dialysis Transplantation
    CrossRef

  4. 4

    H.-K. Wang, S.-Y. Chiou, Y.-C. Lai, H.-Y. Cheng, N.-C. Lin, C.-C. Loong, H.-J. Chiou, Y.-H. Chou, C.-Y. Chang. (2012) Early Postoperative Spectral Doppler Parameters of Renal Transplants: The Effect of Donor and Recipient Factors. Transplantation Proceedings 44:1, 226-229
    CrossRef

  5. 5

    Seok Hwan Jeong, Dae Chul Jung, Sun Ho Kim, Seung Hyup Kim. (2011) Renal venous doppler ultrasonography in normal subjects and patients with diabetic nephropathy: Value of venous impedance index measurements. Journal of Clinical Ultrasound 39:9, 512-518
    CrossRef

  6. 6

    Yoshio Iwashima, Masanobu Yanase, Takeshi Horio, Osamu Seguchi, Yoshihiro Murata, Tomoyuki Fujita, Kouichi Toda, Yuhei Kawano, Takeshi Nakatani. (2011) Effect of Pulsatile Left Ventricular Assist System Implantation on Doppler Measurements of Renal Hemodynamics in Patients With Advanced Heart Failure. Artificial Organsno-no
    CrossRef

  7. 7

    V. Chetboul, T. Daste, V. Gouni, D. Concordet, E. Trehiou-Sechi, F. Serres, J.L. Pouchelon, C.A. Germain, C. Layssol-Lamour, H.P. Lefebvre. (2011) Renal Resistive Index in 55 Dogs with Degenerative Mitral Valve Disease. Journal of Veterinary Internal Medicinen/a-n/a
    CrossRef

  8. 8

    Fan-Fei Tseng, Yu-Hui Huang, Sung-Lang Chen, Su-Ju Tsai, Chi-Chung Ho, Liu-Ing Bih. (2011) Value of Doppler ultrasonography in predicting deteriorating renal function after spinal cord injury. La radiologia medica
    CrossRef

  9. 9

    Brian J Nankivell, Dirk RJ Kuypers. (2011) Diagnosis and prevention of chronic kidney allograft loss. The Lancet 378:9800, 1428-1437
    CrossRef

  10. 10

    T. Kawai, K. Kamide, M. Onishi, H. Yamamoto-Hanasaki, Y. Baba, K. Hongyo, I. Shimaoka, Y. Tatara, Y. Takeya, M. Ohishi, H. Rakugi. (2011) Usefulness of the resistive index in renal Doppler ultrasonography as an indicator of vascular damage in patients with risks of atherosclerosis. Nephrology Dialysis Transplantation 26:10, 3256-3262
    CrossRef

  11. 11

    Szu-Chia Chen, Tsung-Hsien Lin, Po-Chao Hsu, Jer-Ming Chang, Chee-Siong Lee, Wei-Chung Tsai, Ho-Ming Su, Wen-Chol Voon, Hung-Chun Chen. (2011) Impaired left ventricular systolic function and increased brachial-ankle pulse-wave velocity are independently associated with rapid renal function progression. Hypertension Research 34:9, 1052-1058
    CrossRef

  12. 12

    P. Grzelak, M. Sapieha, I. Kurnatowska, M. Nowicki, J. Strzelczyk, L. Stefańczyk. (2011) Contrast-enhanced sonography of postbiopsy arteriovenous fistulas in kidney grafts. Journal of Clinical Ultrasound 39:7, 378-382
    CrossRef

  13. 13

    A. Kolonko, J. Chudek, J. E. Zejda, A. Wiecek. (2011) Impact of early kidney resistance index on kidney graft and patient survival during 5-year follow-up. Nephrology Dialysis Transplantation
    CrossRef

  14. 14

    Javier Barba, Jorge Rioja, José Enrique Robles, Anibal Rincón, David Rosell, Juan Javier Zudaire, José María Berian, Ignacio Pascual, Alberto Benito, Pedro Errasti. (2011) Immediate renal Doppler ultrasonography findings (<24 h) and its association with graft survival. World Journal of Urology 29:4, 547-553
    CrossRef

  15. 15

    Roop Gill, Ron Shapiro, Liise K. Kayler. (2011) Management of peripheral vascular disease compromising renal allograft placement and function: review of the literature with an illustrative case. Clinical Transplantation 25:3, 337-344
    CrossRef

  16. 16

    Asif Sharfuddin. (2011) Imaging Evaluation of Kidney Transplant Recipients. Seminars in Nephrology 31:3, 259-271
    CrossRef

  17. 17

    Khaled M. Elsayes, Christine O. Menias, Jonathon Willatt, Shadi Azar, Howard J. Harvin, Joel F. Platt. (2011) Imaging of Renal Transplant: Utility and Spectrum of Diagnostic Findings. Current Problems in Diagnostic Radiology 40:3, 127-139
    CrossRef

  18. 18

    N. J. Buchner, K. R. Wissing, J. Stegbauer, I. Quack, S. M. Weiner, B. K. Kramer, L. C. Rump. (2011) The renal resistance index is increased in mild-to-moderate obstructive sleep apnoea and is reduced under continuous positive airway pressure. Nephrology Dialysis Transplantation 26:3, 914-920
    CrossRef

  19. 19

    Toshihiro Sugiura, Akira Wada. (2011) Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up. Clinical and Experimental Nephrology 15:1, 114-120
    CrossRef

  20. 20

    Michael Darmon, Frédérique Schortgen, Frederic Vargas, Aissam Liazydi, Benoît Schlemmer, Christian Brun-Buisson, Laurent Brochard. (2011) Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Medicine 37:1, 68-76
    CrossRef

  21. 21

    Elizabeth Marti, Ivo P. Bergmann, Dominik E. Uehlinger, Felix J. Frey, Ute Eisenberger. (2011) Donor Effect on Cortical Perfusion Intensity in Renal Allograft Recipients: A Paired Kidney Analysis. American Journal of Nephrology 33:6, 530-536
    CrossRef

  22. 22

    Grant M. Baxter. 2011. Renal transplantation. , 528-549.
    CrossRef

  23. 23

    U. Raff, T. K. Schwarz, B. M. W. Schmidt, M. P. Schneider, R. E. Schmieder. (2010) Renal resistive index--a valid tool to assess renal endothelial function in humans?. Nephrology Dialysis Transplantation 25:6, 1869-1874
    CrossRef

  24. 24

    Mario Rotondi, Giuseppe Stefano Netti, Elena Lazzeri, Giovanni Stallone, Elisabetta Bertoni, Luca Chiovato, Giuseppe Grandaliano, Loreto Gesualdo, Maurizio Salvadori, Francesco Paolo Schena, Paola Romagnani, Mario Serio. (2010) High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. Transplant International 23:5, 465-475
    CrossRef

  25. 25

    M. K. Gerhart, S. Seiler, O. S. Grun, K. S. Rogacev, D. Fliser, G. H. Heine. (2010) Indices of systemic atherosclerosis are superior to ultrasound resistance indices for prediction of allograft survival. Nephrology Dialysis Transplantation 25:4, 1294-1300
    CrossRef

  26. 26

    Ulrike Raff, Bernhard MW Schmidt, Johannes Schwab, Thomas K Schwarz, Stephan Achenbach, Ingrid Bär, Roland E Schmieder. (2010) Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension. Journal of Hypertension 28:3, 608-614
    CrossRef

  27. 27

    Jeffrey D. Pearce, Timothy E. Craven, Matthew S. Edwards, Matthew A. Corriere, Teresa A. Crutchley, Shawn H. Fleming, Kimberley J. Hansen. (2010) Associations Between Renal Duplex Parameters and Adverse Cardiovascular Events in the Elderly: A Prospective Cohort Study. American Journal of Kidney Diseases 55:2, 281-290
    CrossRef

  28. 28

    Massimo Meco, Silvia Cirri. (2010) Effects of Fenoldopam Mesylate on Central Hemodynamics and Renal Flow in Patients Undergoing Cardiac Surgery: Color Doppler Echocardiographic Evaluation. Journal of Cardiothoracic and Vascular Anesthesia 24:1, 58-62
    CrossRef

  29. 29

    Sepideh Gholami, Minnie M. Sarwal, Maarten Naesens, Hans G. Ringertz, Richard A. Barth, Raymond R. Balise, Oscar Salvatierra. (2010) Standardizing resistive indices in healthy pediatric transplant recipients of adult-sized kidneys. Pediatric Transplantation 14:1, 126-131
    CrossRef

  30. 30

    G. Ploussard, P. Mongiat-Artus, P. Meria, E. Tariel, F. Gaudez, E. De Kerviler, C. Legendre, M.-N. Peraldi, D. Glotz, F. Desgrandchamps. (2010) What is the relevance of systematic aorto-femoral Doppler ultrasound in the preoperative assessment of patients awaiting first kidney transplantation: a monocentric prospective study. Nephrology Dialysis Transplantation 25:1, 270-274
    CrossRef

  31. 31

    N. Mitsides, P. Maginnis, A. Woywodt. (2009) The 'Double Dutch' Doppler. NDT Plus 2:6, 495-497
    CrossRef

  32. 32

    K.F. Stock. (2009) Ultraschalldiagnostik der Nierengefäße und der Transplantatniere. Der Radiologe 49:11, 1040-1047
    CrossRef

  33. 33

    Carlos Jimenez, María Ovidea Lopez, Elena Gonzalez, Rafael Selgas. (2009) Ultrasonography in kidney transplantation: values and new developments. Transplantation Reviews 23:4, 209-213
    CrossRef

  34. 34

    T. Sugiura, A. Wada. (2009) Resistive index predicts renal prognosis in chronic kidney disease. Nephrology Dialysis Transplantation 24:9, 2780-2785
    CrossRef

  35. 35

    Rachel E. Pollard, Paul A. Dayton, Katherine D. Watson, Xiaowen Hu, Ismayil M. Guracar, Katherine W. Ferrara. (2009) Motion Corrected Cadence CPS Ultrasound for Quantifying Response to Vasoactive Drugs in a Rat Kidney Model. Urology 74:3, 675-681
    CrossRef

  36. 36

    Jordi Rovira, Edgar M. Arellano, Joaquim Carreras, Begoña Campos, Barbara Vodenik, Elisenda Bañón-Maneus, María José Ramírez-Bajo, Daniel Moya-Rull, Amanda Solé-González, Astrid Hernández, Ignacio Revuelta, Luis F. Quintana, William J. Howat, Josep M. Campistol, Fritz Diekmann. (2009) Mammalian Target of Rapamycin Inhibition Prevents Glomerular Hypertrophy in a Model of Renal Mass Reduction. Transplantation 88:5, 646-652
    CrossRef

  37. 37

    Ute Eisenberger, Daniel Sollinger, Felix Stickel, Beat Burckhardt, Felix J. Frey. (2009) Relationship between renal resistance index and renal function in liver transplant recipients after cessation of calcineurin inhibitor. Clinical Transplantation 23:4, 499-504
    CrossRef

  38. 38

    Ivo P. Bergmann, Rainer H. Böger, Elizabeth Marti, Felix J. Frey, Edzard Schwedhelm, Ute Eisenberger. (2009) Renal Resistance Index in Renal Allograft Recipients: A Role for ADMA. American Journal of Kidney Diseases 54:2, 327-333
    CrossRef

  39. 39

    M. Masulli, M. Mancini, R. Liuzzi, S. Daniele, P.P. Mainenti, E. Vergara, S. Genovese, M. Salvatore, O. Vaccaro. (2009) Measurement of the intrarenal arterial resistance index for the identification and prediction of diabetic nephropathy. Nutrition, Metabolism and Cardiovascular Diseases 19:5, 358-364
    CrossRef

  40. 40

    Ping-Liang Yang, David T. Wong, Shuang-Bo Dai, Hai-Bo Song, Ling Ye, Jin Liu, Bin Liu. (2009) The Feasibility of Measuring Renal Blood Flow Using Transesophageal Echocardiography in Patients Undergoing Cardiac Surgery. Anesthesia & Analgesia 108:5, 1418-1424
    CrossRef

  41. 41

    Mark-Hugo J. Maathuis, Martijn de Groot, Rutger J. Ploeg, Henri G.D. Leuvenink. (2009) Deterioration of Endothelial and Smooth Muscle Cell Function in DCD Kidneys After Static Cold Storage in IGL-1 or UW. Journal of Surgical Research 152:2, 231-237
    CrossRef

  42. 42

    Teresa A. Crutchley, Jeffrey D. Pearce, Timothy E. Craven, Jeanette M. Stafford, Matthew S. Edwards, Kimberley J. Hansen. (2009) Clinical utility of the resistive index in atherosclerotic renovascular disease. Journal of Vascular Surgery 49:1, 148-155.e3
    CrossRef

  43. 43

    Miodrag Antic, Aleksandra Jotic, Milan Radovic, Jelena Seferovic, Nebojsa Lalic, Dijana Jovanovic, Visnja Lezaic. (2009) Risk factors for the development of diabetic nephropathy. Srpski arhiv za celokupno lekarstvo 137:1-2, 18-26
    CrossRef

  44. 44

    Yio-Wha Shau, Sun-Hua Pao, Nai-Kuan Chou, King-Jen Chang, Jeou-Jong Shyu. (2009) Renal Vascular Perfusion Index in a Canine Model. Ultrasound in Medicine & Biology 35:1, 36-43
    CrossRef

  45. 45

    Arzu Akgul, Avsin Ibis, Siren Sezer, Ceyla Basaran, Alper Usluogullari, Fatma Nurhan Ozdemir, Zubeyde Arat, Mehmet Haberal. (2009) Early Assessment of Renal Resistance Index and Long-Term Renal Function in Renal Transplant Recipients. Renal Failure 31:1, 18-24
    CrossRef

  46. 46

    Michael Neipp, Steffan Jackobs, Jürgen Klempnauer. (2009) Renal transplantation today. Langenbeck's Archives of Surgery 394:1, 1-16
    CrossRef

  47. 47

    M. Aschwanden, M. Mayr, S. Imfeld, J. Steiger, K. A. Jaeger, C. Thalhammer. (2008) Rapid adaptation of the intrarenal resistance index after living donor kidney transplantation. Nephrology Dialysis Transplantation 24:4, 1331-1334
    CrossRef

  48. 48

    Jacques Duranteau, Stéphane Deruddre, Bernard Vigue, Denis Chemla. (2008) Doppler monitoring of renal hemodynamics: why the best is yet to come. Intensive Care Medicine 34:8, 1360-1361
    CrossRef

  49. 49

    Emmanuel Letavernier, Christophe Legendre. (2008) mToR inhibitors-induced proteinuria: mechanisms, significance, and management. Transplantation Reviews 22:2, 125-130
    CrossRef

  50. 50

    Behzad Najafian, Bertram L Kasiske. (2008) Chronic allograft nephropathy. Current Opinion in Nephrology and Hypertension 17:2, 149-155
    CrossRef

  51. 51

    Brian J. Nankivell. 2008. Chronic Allograft Nephropathy. , 416-438.
    CrossRef

  52. 52

    Mark E. Lockhart, Michelle L. Robbin. (2007) Renal Vascular Imaging. Ultrasound Quarterly 23:4, 279-292
    CrossRef

  53. 53

    Stéphane Deruddre, Gaëlle Cheisson, Jean-Xavier Mazoit, Eric Vicaut, Dan Benhamou, Jacques Duranteau. (2007) Renal arterial resistance in septic shock: effects of increasing mean arterial pressure with norepinephrine on the renal resistive index assessed with Doppler ultrasonography. Intensive Care Medicine 33:9, 1557-1562
    CrossRef

  54. 54

    Raffaele Girlanda, Roslyn B. Mannon, Allan D. Kirk. (2007) Diagnostic Tools for Monitoring Kidney Transplant Recipients. Seminars in Nephrology 27:4, 462-478
    CrossRef

  55. 55

    Vedat Schwenger, Ulrich-Paul Hinkel, Anna-Maria Nahm, Christian Morath, Martin Zeier. (2006) Real-time contrast-enhanced sonography in renal transplant recipients. Clinical Transplantation 20:s17, 51-54
    CrossRef

  56. 56

    V. Schwenger, T. Keller, N. Hofmann, O. Hoffmann, C. Sommerer, A. M. Nahm, C. Morath, M. Zeier, B. Krumme. (2006) Color Doppler Indices of Renal Allografts Depend on Vascular Stiffness of the Transplant Recipients. American Journal of Transplantation 6:11, 2721-2724
    CrossRef

  57. 57

    C. Blume, C. E. Kurschat, U. Helmchen, B. Grabensee. (2006) Chronische Transplantatdysfunktion. Der Nephrologe 1:4, 241-254
    CrossRef

  58. 58

    C. A. Boger, P. Rummele, M. J. Mihatsch, B. Banas, B. K. Kramer. (2006) Reverse Diastolic Intrarenal Flow Due to Calcineurin Inhibitor (CNI) Toxicity. American Journal of Transplantation 6:8, 1963-1967
    CrossRef

  59. 59

    Martin Schumacher, U.E. Studer, H. Danuser. (2006) Antegrade Endopyelotomy for Treatment of Ureteropelvic Junction Obstruction in Transplanted Kidneys. Journal of Endourology 20:5, 305-308
    CrossRef

  60. 60

    V. Schwenger, G. Korosoglou, U.-P. Hinkel, C. Morath, A. Hansen, C. Sommerer, R. Dikow, S. Hardt, J. Schmidt, H. Kucherer, H.A. Katus, M. Zeier. (2006) Real-Time Contrast-Enhanced Sonography of Renal Transplant Recipients Predicts Chronic Allograft Nephropathy. American Journal of Transplantation 6:3, 609-615
    CrossRef

  61. 61

    Thomas Scholbach, Elisa Girelli, Jakob Scholbach. (2006) Tissue Pulsatility Index: A New Parameter to Evaluate Renal Transplant Perfusion. Transplantation 81:5, 751-755
    CrossRef

  62. 62

    KRISTYN D. BROADDUS, D. MICHAEL TILLSON, STEPHEN D. LENZ, GLENN P. NIEMEYER, WILLIAM R. BRAWNER, JANET A. WELCH, CLINTON D. LOTHROP. (2006) Renal Allograft Histopathology in Dog Leukocyte Antigen Mismatched Dogs After Renal Transplantation. Veterinary Surgery 35:2, 125-135
    CrossRef

  63. 63

    A. P. J. de Vries, W. J. van Son, J. J. Homan van der Heide, R. J. Ploeg, G. Navis, P. E. de Jong, R. O. B. Gans, S. J. L. Bakker, R. T. Gansevoort. (2006) The Predictive Value of Renal Vascular Resistance for Late Renal Allograft Loss. American Journal of Transplantation 6:2, 364-370
    CrossRef

  64. 64

    Daniel C Brennan, Krista L Lentine. (2006) Is there a correlation between atherosclerosis and renal resistive indices in kidney transplant recipients?. Nature Clinical Practice Nephrology 2:2, 64-65
    CrossRef

  65. 65

    Vedat Schwenger, Ulrich Paul Hinkel, Anna-Maria Nahm, Christian Morath, Martin Zeier. (2006) Color Doppler Ultrasonography in the Diagnostic Evaluation of Renal Allografts. Nephron Clinical Practice 104:3, c107-c112
    CrossRef

  66. 66

    Bernd Krumme. (2006) Renal Doppler Sonography &ndash; Update in Clinical Nephrology. Nephron Clinical Practice 103:2, c24-c28
    CrossRef

  67. 67

    T. Leiner, M. W. Haan, P. J. Nelemans, J. M. A. Engelshoven, G. B. C. Vasbinder. (2005) Contemporary imaging techniques for the diagnosis of renal artery stenosis. European Radiology 15:11, 2219-2229
    CrossRef

  68. 68

    Emmanuel Letavernier, Marie-No??lle Pe???raldi, Antoine Pariente, Emmanuel Morelon, Christophe Legendre. (2005) Proteinuria Following a Switch from Calcineurin Inhibitors to Sirolimus. Transplantation 80:9, 1198-1203
    CrossRef

  69. 69

    Martin Hausberg, Detlef Lang, Michael Barenbrock, Markus Kosch. (2005) What do Doppler indices of renal perfusion tell us for the evaluation of renal disease?. Journal of Hypertension 23:10, 1795-1797
    CrossRef

  70. 70

    GUNNAR H HEINE, MARKUS K GERHART, CHRISTOF ULRICH, HANS KÖHLER, MATTHIAS GIRNDT. (2005) Renal Doppler resistance indices are associated with systemic atherosclerosis in kidney transplant recipients. Kidney International 68:2, 878-885
    CrossRef

  71. 71

    Adina Voiculescu, Michael Schmitz, Markus Hollenbeck, Sabine Braasch, Bernd Luther, Wilhelm Sandmann, Gregor Jung, Ulrich Modder, Bernd Grabensee. (2005) Management of Arterial Stenosis Affecting Kidney Graft Perfusion: A Single-Centre Study in 53 Patients. American Journal of Transplantation 5:7, 1731-1738
    CrossRef

  72. 72

    Thomas Scholbach, Elisa Girelli, Jakob Scholbach. (2005) Dynamic Tissue Perfusion Measurement: A Novel Tool in Follow-Up of Renal Transplants. Transplantation 79:12, 1711-1716
    CrossRef

  73. 73

    Eric A. Elster, Douglas A. Hale, Roslyn B. Mannon, Linda C. Cendales, David Kleiner, S. John Swanson, Allan D. Kirk. (2005) Surgical transplant physical examination: Correlation of renal resistance index and biopsy-proven chronic allograft nephropathy. Journal of the American College of Surgeons 200:4, 552-556
    CrossRef

  74. 74

    Lars Pape, Michael Mengel, Gisela Offner, Michael Melter, Jochen H. H. Ehrich, Juergen Strehlau. (2004) Renal arterial resistance index and computerized quantification of fibrosis as a combined predictive tool in chronic allograft nephropathy. Pediatric Transplantation 8:6, 565-570
    CrossRef

  75. 75

    Rainer Bscher, Udo Vester, A.-M. Wingen, Peter F. Hoyer. (2004) Pathomechanisms and the diagnosis of arterial hypertension in pediatric renal allograft recipients. Pediatric Nephrology 19:11, 1202-1211
    CrossRef

  76. 76

    Ondřej Viklický, Jaroslav A. Hubáček, Jan Kvasnička, Ivo Matl, Luděk Voska, Jelena Skibová, Vladimı́r Teplan, Štefan Vı́tko. (2004) Association of methylenetetrahydrofolate reductase T677 allele with early development of chronic allograft nephropathy. Clinical Biochemistry 37:10, 919-924
    CrossRef

  77. 77

    SEJOONG KIM, JAY WOOK LEE, JUNGHWAN PARK, KI YOUNG NA, KWON WOOK JOO, CURIE AHN, SUHNGGWON KIM, JUNG SANG LEE, GHEUN-HO KIM, JIN KIM, JIN SUK HAN. (2004) The urine-blood PCO2 gradient as a diagnostic index of H+-ATPase defect distal renal tubular acidosis. Kidney International 66:2, 761-767
    CrossRef

  78. 78

    Ulkem Yakupoglu, Elzbieta Baranowska-Daca, Daniel Rosen, Roberto Barrios, Wadi N. Suki, Luan D. Truong. (2004) Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney International 65:6, 2360-2370
    CrossRef

  79. 79

    Ravi Raju Tatapudi, Thangamani Muthukumar, Darshana Dadhania, Ruchuang Ding, Baogui Li, Vijay K. Sharma, Elizabeth Lozada-Pastorio, Nagashree Seetharamu, Choli Hartono, David Serur, Surya V. Seshan, Sandip Kapur, Wayne W. Hancock, Manikkam Suthanthiran. (2004) Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney International 65:6, 2390-2397
    CrossRef

  80. 80

    Michel Eichelbaum, Martin F. Fromm, Matthias Schwab. (2004) Clinical Aspects of the MDR1 (ABCB1) Gene Polymorphism. Therapeutic Drug Monitoring 26:2, 180-185
    CrossRef

  81. 81

    Bertram L. Kasiske. (2003) Endpoint or Turning Point?. American Journal of Transplantation 3:12, 1463-1464
    CrossRef

  82. 82

    (2003) Renal Arterial Resistance Index. New England Journal of Medicine 349:16, 1573-1574
    Full Text

  83. 83

    Marsden, Philip A., . (2003) Predicting Outcomes after Renal Transplantation — New Tools and Old Tools. New England Journal of Medicine 349:2, 182-184
    Full Text

Letters